MyFinsight
Home
Blog
About
Cash and cash
equivalents
$18,617K
(214.58%↑ Y/Y)
Other prepaid
expenses and current...
$575K
(-12.21%↓ Y/Y)
Prepaid clinical trial
expenses
$228K
(-35.23%↓ Y/Y)
Assets held for sale
$43K
Total current assets
$19,463K
(2.63%↑ Y/Y)
Property and equipment,
net
$36K
(-65.71%↓ Y/Y)
Other assets
$4K
(-63.64%↓ Y/Y)
Total assets
$19,503K
(2.22%↑ Y/Y)
Total liabilities and
stockholders' equity...
$19,503K
(2.22%↑ Y/Y)
Total liabilities
$13,990K
(7.81%↑ Y/Y)
Total stockholders'
equity (deficit)
$5,513K
(-9.67%↓ Y/Y)
Accumulated deficit
-$192,002K
(-12.44%↓ Y/Y)
Accumulated other
comprehensive loss
-$1K
(75.00%↑ Y/Y)
Promissory note
$9,200K
(8.24%↑ Y/Y)
Total current
liabilities
$3,490K
(0.37%↑ Y/Y)
Warrant liability
$1,300K
(30.00%↑ Y/Y)
Additional paid-in capital
$197,510K
(11.67%↑ Y/Y)
Common stock, 0.0001
par value...
$6K
(50.00%↑ Y/Y)
Accounts payable
$2,073K
(8.42%↑ Y/Y)
Accrued expenses
$1,224K
(36.76%↑ Y/Y)
Accrued clinical trial
costs
$193K
(-71.19%↓ Y/Y)
Back
Back
Balance Sheet
CalciMedica, Inc. (CALC)
CalciMedica, Inc. (CALC)
source: myfinsight.com